The KDM3A/KLF5/SMAD4/EGFR axis (Figure 4, Table 2) coordinates the regulatory mechanism involved in maintaining a low population of T cells within the tumor microenvironment (TME), thus driving resistance to immunotherapies. This evidence concerns the gene KLF5 and neoplasm.